FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. The company also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, a cloud-based electronic medical chart for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $17.07 | N/A |
Market Cap | $179.29M | N/A |
Shares Outstanding | 10.51M | 0.78% |
Employees | 1.16K | N/A |
Shareholder Equity | 26.59B | 13.26% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.08 | N/A |
P/S Ratio | 0.55 | N/A |
P/B Ratio | 0.01 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0006 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $327.32M | N/A |
Earnings | $15.78M | N/A |
EPS | 214.03 | N/A |
Earnings Yield | 12.54 | N/A |
Gross Margin | 0.3122 | N/A |
Operating Margin | 0.0656 | N/A |
Net income margin | 0.0482 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $271.34M | N/A |
Total Debt | $19.54M | N/A |
Cash on Hand | $87.93M | N/A |
Debt to Equity | 0.0032 | -35.26% |
Cash to Debt | $4.50 | 71.98% |
Current Ratio | $2.37 | 19.28% |